BioCentury
ARTICLE | Company News

Alkermes hGH deal with Lilly

February 8, 2000 8:00 AM UTC

ALKS will use its AIR pulmonary drug delivery technology to develop an inhaled formulation of human growth hormone (hGH) for LLY. ALKS will receive upfront fees, research funding and milestones, and i...